NSAID toxicity

Digestive Disease Week® (DDW)

May 6, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents

Jan. 2, 2017

The use of platelet transfusions in patients with GIB who are taking antiplatelet agents without thrombocytopenia did not reduce rebleeding but was associated with higher mortality.

Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes

Oct. 28, 2016

Based on data from the prospective cohort studies, regular use of aspirin is associated with a lower risk of colorectal carcinomas with low concentrations of TILs.

Take the #OTCSmart Pledge for Pain Safety Action Day

Sept. 15, 2016

Join AGA on Sept. 26 to spread the word about the safe use of over-the-counter pain medicines.

Risks of Bleeding Recurrence and Cardiovascular Events With Continued Aspirin Use After Lower Gastrointestinal Hemorrhage

Aug. 1, 2016

Among aspirin users with a history of lower GI bleeding, continuation of aspirin is associated with an increased risk of recurrent lower GI bleeding, but reduced risk of serious cardiovascular events and death.

Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug–Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial

June 1, 2016

In a randomized, controlled trial, PPIs increased the risk of short-term nonsteroidal anti-inflammatory drug–induced small bowel injury.

DDSEP 8 - Question Bank Only

April 12, 2016

Assess your knowledge with more than 800 questions, answers and rationales.
Advertisement

DDSEP 8 - Complete

April 12, 2016

The eighth edition of AGA's premier GI education program features new and expanded content to help you enhance your knowledge, build expertise and improve patient care.

Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients

March 31, 2016

Dr. John M. Levenick discusses his manuscript "Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients." To view abstract click here http://bit.ly/1UWvoO3.

2015 SPGC Syllabus Now Available

Aug. 4, 2015

The 2015 AGA Spring Postgraduate Course syllabus is now available for purchase in both electronic and print formats.

Evaluation of Pharmacologic Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Systematic Review

June 23, 2015

On the basis of a systematic review, NSAIDs are appropriate for use in prevention of PEP, especially for high-risk cases. Additional research is necessary to clarify the role of other pharmacologic agents. These findings could inform future research and guide clinical decision-making and policy.

Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System

June 1, 2015

We aimed to determine the incidence and outcomes of drug-induced ALF in an integrated health care system that approximates a population-based cohort.

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

June 1, 2015

The Drug-Induced Liver Injury Network is conducting a prospective study of patients with DILI in the United States. We present characteristics and subgroup analyses from the first 1257 patients enrolled in the study.

Stay Up-to-Date with AGA Journal Podcasts

July 3, 2014

Download the latest journal podcasts on popular articles from Gastroenterology and Clinical Gastroenterology and Hepatology.

CGH Podcast June 2014: PPIs and NSAID–Related Lower Gastrointestinal Adverse Events

June 10, 2014

AGA Launches Exciting New Medicine Safety Campaign

Feb. 20, 2014

AGA has launched a new education campaign — Gut Check: Know Your Medicine — to help reduce the amount of preventable harm caused by unintentional overdose of common over-the-counter pain medicines ingredients.

Understand the Newest Approaches for Treating Hepatitis C

Feb. 20, 2014

Register today for the 2014 AGA Spring Postgraduate Course to learn new and alternative approaches to treating common GI conditions, including hepatitis C.

Save the Date: 2014 AGA Spring Postgraduate Course

Dec. 5, 2013

This year's course is set to take place Saturday, May 3, and Sunday, May 4, in Chicago, IL. Save the date to attend and learn new and improved approaches to clinical problems seen in everyday practice.

Co-prescription of Gastroprotective Agents and Their Efficacy in Elderly Patients Taking Nonsteroidal Anti-inflammatory Drugs: A Systematic Review of Observational Studies

Sept. 24, 2013

Failure to Renew Prescriptions for Gastroprotective Agents to Patients on Continuous NSAIDs Increases Rate of Upper GI Injury

May 2, 2013

Isabelle Le Ray and colleagues conclude in Clinical Gastroenterology and Hepatology that within two years after prescribing a proton pump inhibitor (PPI), physicians do not renew this prescription for approximately 33 percent of patients receiving continuous nonsteroidal anti-inflammatory drugs (NSAIDs). This increases the risk for GI adverse events among these patients.

Failure to Renew Prescriptions for Gastroprotective Agents to Patients on Continuous Nonsteroidal Anti-inflammatory Drugs Increases Rate of Upper Gastrointestinal Injury

April 23, 2013

Discontinuation of Low-Dose Aspirin Therapy After Peptic Ulcer Bleeding Increases Risk of Death and Acute Cardiovascular Events

Jan. 3, 2013

Factors Associated With Positive Findings From Capsule Endoscopy in Patients With Obscure Gastrointestinal Bleeding

Nov. 27, 2012

Helicobacter pylori Infection and Nonsteroidal Anti-inflammatory Drug Use: Eradication, Acid-Reducing Therapy, or Both?

July 26, 2012